You have 3 free searches left this month | for more free features.

City

Guangzhou (1)

Shanghai (1)

Condition

Metastatic Endometrial Carcinoma (1)

Neuroendocrine Tumors (1)

Recurrent Endometrial Carcinoma (1)

Recurrent Fallopian Tube Carcinoma (1)

Recurrent Platinum-Resistant Ovarian Carcinoma (1)

Recurrent Primary Peritoneal Carcinoma (1)

Stage III Uterine Corpus Cancer AJCC v8 (1)

Stage IV Uterine Corpus Cancer AJCC v8 (1)

Unresectable Endometrial Carcinoma (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Phase

phase 1 (2)

Sponsor

Ascentage Pharma Group Inc. (1)

National Cancer Institute (NCI) (1)

Collaborator

Intervention

pelcitoclax (2)

biopsy (1)

biospecimen collection (1)

cobimetinib (1)

computed tomography (1)

magnetic resonance imaging (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

Industry (1)

NIH (1)

Study Type

Interventional (2)

pelcitoclax

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Neuroendocrine Tumors Trial in Guangzhou, Shanghai (Pelcitoclax)

Recruiting

Neuroendocrine Tumors

Pelcitoclax

Guangzhou, Guangdong, China
+2 more

Jan 21, 2022

Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen

Not yet recruiting

Metastatic Endometrial Carcinoma
+7 more

Biopsy
+5 more

(no location specified)

Jan 18, 2023